通过延迟强化磁共振成像检测出的心脏结节病
Cardiac sarcoidosis detected by delayed-hyperenhancement magnetic resonance imaging.
作者信息
Nemeth Margit A, Muthupillai Raja, Wilson James M, Awasthi Mukta, Flamm Scott D
机构信息
Department of Cardiology, St. Luke's Episcopal Hospital, Texas Heart Institute, Houston, Texas 77030, USA.
出版信息
Tex Heart Inst J. 2004;31(1):99-102.
Abstract
We report the case of a patient with sarcoidosis and ventricular tachycardia in whom cardiac magnetic resonance imaging provided supportive evidence of cardiac involvement by delineating regions of myocardial inflammation and fibrosis inconsistent with ischemic injury. The identification of cardiac involvement in patients with sarcoidosis is problematic, and the true incidence is unknown. Cardiac magnetic resonance imaging may help establish the actual incidence of cardiac involvement and allow further advances in monitoring and treatment options.
摘要
我们报告了一例患有结节病和室性心动过速的患者，心脏磁共振成像通过描绘与缺血性损伤不符的心肌炎症和纤维化区域，为心脏受累提供了支持性证据。结节病患者心脏受累的识别存在问题，其真实发病率尚不清楚。心脏磁共振成像可能有助于确定心脏受累的实际发病率，并推动监测和治疗方案的进一步发展。
相似文献
1
Cardiac sarcoidosis detected by delayed-hyperenhancement magnetic resonance imaging.
Tex Heart Inst J. 2004;31(1):99-102.
2
Ventricular aneurysms in cardiac sarcoidosis: From physiopathology to surgical treatment through a clinical case presenting with ventricular arrhythmias.
Int J Cardiol. 2015;186:294-6. doi: 10.1016/j.ijcard.2015.03.256. Epub 2015 Mar 19.
3
Images in cardiovascular medicine. Cardiac sarcoidosis evaluated by delayed-enhanced magnetic resonance imaging.
Circulation. 2003 May 27;107(20):e188-9. doi: 10.1161/01.CIR.0000062400.74155.E6.
4
Correlation of late gadolinium enhancement MRI and quantitative T2 measurement in cardiac sarcoidosis.
J Magn Reson Imaging. 2014 Mar;39(3):609-16. doi: 10.1002/jmri.24196. Epub 2013 May 29.
5
Effectiveness of delayed enhanced MRI for identification of cardiac sarcoidosis: comparison with radionuclide imaging.
AJR Am J Roentgenol. 2005 Jul;185(1):110-5. doi: 10.2214/ajr.185.1.01850110.
6
Pleomorphism during Ventricular Tachycardia: A Distinguishing Feature between Cardiac Sarcoidosis and Idiopathic VT.
Pacing Clin Electrophysiol. 2015 Jun;38(6):694-9. doi: 10.1111/pace.12626. Epub 2015 Apr 14.
7
Diagnosis of right ventricular cardiac sarcoidosis with cardiac magnetic resonance in a patient presenting with ventricular tachycardia.
Mil Med. 2013 Feb;178(2):e265-70. doi: 10.7205/MILMED-D-12-00288.
8
MRI of cardiac sarcoidosis: basal and subepicardial localization of myocardial lesions and their effect on left ventricular function.
AJR Am J Roentgenol. 2008 Sep;191(3):862-9. doi: 10.2214/AJR.07.3089.
9
Magnetic resonance imaging for identifying patients with cardiac sarcoidosis and preserved or mildly reduced left ventricular function at risk of ventricular arrhythmias.
Circ Arrhythm Electrophysiol. 2014 Dec;7(6):1109-15. doi: 10.1161/CIRCEP.113.000156. Epub 2014 Sep 29.
10
Cardiac sarcoidosis detected with magnetic resonance imaging.
Eur Heart J. 2006 Jul;27(14):1639. doi: 10.1093/eurheartj/ehi699. Epub 2006 Jan 25.
引用本文的文献
1
CMR Features in Cardiac Sarcoidosis.
Case Rep Radiol. 2011;2011:702984. doi: 10.1155/2011/702984. Epub 2011 Jul 13.
2
Usefulness of late gadolinium enhancement combined with MRI and 67-Ga scintigraphy in the diagnosis of cardiac sarcoidosis and disease activity evaluation.
Int J Cardiovasc Imaging. 2007 Apr;23(2):237-41. doi: 10.1007/s10554-006-9134-3. Epub 2006 Jul 26.
本文引用的文献
1
A study of sarcoidosis; based on a combined investigation of 160 cases including 30 autopsies from The Johns Hopkins Hospital and Massachusetts General Hospital.
Medicine (Baltimore). 1952 Feb;31(1):1-132.
2
Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: a 1-year follow-up study.
Chest. 2002 Dec;122(6):1895-901. doi: 10.1378/chest.122.6.1895.
3
Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury.
Circulation. 2002 Jan 15;105(2):224-9. doi: 10.1161/hc0202.102016.
4
Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography.
Circulation. 2002 Jan 15;105(2):162-7. doi: 10.1161/hc0202.102123.
5
The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction.
N Engl J Med. 2000 Nov 16;343(20):1445-53. doi: 10.1056/NEJM200011163432003.
6
Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function.
Circulation. 1999 Nov 9;100(19):1992-2002. doi: 10.1161/01.cir.100.19.1992.
7
Cardiac sarcoidosis: the value of magnetic resonance imaging in diagnosis and assessment of response to treatment.
Respir Med. 1998 Apr;92(4):697-9. doi: 10.1016/s0954-6111(98)90522-4.
8
Diagnosis of cardiac sarcoidosis aided by MRI.
Chest. 1996 Aug;110(2):562-5. doi: 10.1378/chest.110.2.562.
9
Myocardial sarcoidosis.
Chest. 1993 Jan;103(1):253-8. doi: 10.1378/chest.103.1.253.
10
Causes of death in patients with sarcoidosis. A morphologic study of 38 autopsies with clinicopathologic correlations.
Arch Pathol Lab Med. 1995 Feb;119(2):167-72.
Zotero 插件